Tickborne encephalitis (TBE) is a viral infectious disease that attacks the central nervous system and can result in long-term neurological symptoms, and even death.
Meningococcal disease is caused by Neisseria meningitidis, a bacterium with human carriers as the only reservoir. It is carried in the nose, where it can remain for long periods without producing symptoms.
Despite good access to effective antibiotics, Streptococcus pneumoniae (pneumococci) is still a major cause of disease and death in both developing and developed countries. Pneumococci are the main cause of bacterial respiratory tract infections, such as pneumonia, middle ear infection, and sinusitis, in all age groups.
Marburg virus disease (MVD), formerly known as Marburg haemorrhagic fever, is a severe disease in humans caused by Marburg marburgvirus (MARV). Although MVD is uncommon, MARV has the potential to cause epidemics with significant case fatality rates.
Borreliosis, also known as Lyme disease, is caused by the bacterium Borrelia burgdorferi and is transmitted to humans by the bite of infected ticks. If left untreated, infection can spread to joints, the heart, and the nervous system. Most cases of Borreliosis can be treated successfully with a few weeks of antibiotics. No vaccine against Borreliosis is currently available.
The information sheet is mainly intended for people living in endemic areas who have been bitten by (a) tick(s) so as to inform them primarily about the symptoms that they have to be aware of.(Adaptable templates available)
Cryptosporidia are intestinal parasites infecting a variety of animals (e.g. cattle, sheep, rodents, cats and dogs, but also birds, fish and reptiles). Human infections occur due to Cryptosporidium parvum, a species that also affects domestic animals.
Borreliosis, also known as Lyme disease, is transmitted by the bite of infected ticks. Most cases can be treated with antibiotics. No vaccine is available.
Crimean-Congo haemorrhagic fever is an emerging pathogen in Europe. Outbreaks have a case fatality rate between 5% and 40%. There is no validated therapy and no safe vaccine.